Over 70 California Auctions End Today - Bid Now
Over 200 Total Lots Up For Auction at One Location - UT 06/15

Interventional radiologists save patient's leg in a first-in-human compassionate use of VeinWay's Traversa

Press releases may be edited for formatting or style | March 02, 2023 Business Affairs X-Ray
ANN ARBOR, Mich. and OR YEHUDA, Israel, March 2, 2023 /PRNewswire/ -- In a first-in-human, compassionate use case approved by the U.S. Food and Drug Administration, University of Michigan Health Interventional Radiologists Dr. David M. Williams and Dr. Minhaj S. Khaja successfully used VeinWay's Traversa for venous recanalization to save a patient's leg that was close to being amputated.

Traversa, a newly developed tool for crossing tough occlusions in veins, enabled the physicians to recanalize a previously uncrossable vascular pathway, which included a 20 cm long blocked vein with four occluded stents.

University of Michigan Health Interventional Radiologist Dr. David M. Williams, "I had crossed the segment in this patient three years ago, but today it would have been impossible with existing devices. The patient's leg was in desperate condition. Traversa not only made this procedure possible, but also much easier and impressively faster."
DOTmed text ad

Reveal 35C: spectral bedside imaging, no extra dose, now available in the EU

KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at sales@kaimaging.com to book a free demo.

University of Michigan Health Interventional Radiologist Dr. Minhaj S. Khaja said, "The device allowed us to take the path that we wanted rather than being forced to trouble shoot the path chosen by the sharp recanalization devices available today. With Traversa, we were able to choose the angle and the length of the throw of the needle. This enabled us to pick the pathway and if we didn't like it, we were able to readjust. I think that allowed us to safely get through the occlusions and the stents."

VeinWay CEO Mr. Jordan Pollack said, "Our mission is to give surgeons the control they need to recanalize the veins of their patients safely, timely and successfully. In doing so, we hope to inspire physicians to perform more venous recanalizations for the patients that need it to relieve pain and improve mobility. The procedure at University of Michigan Health was a huge step in changing the medical landscape of venous recanalization. We would like to thank the FDA for approving the use of Traversa in this first compassionate use case as well as Drs. Williams and Khaja for their agreement to try something new. We were honored to be of service."

About University of Michigan Health, Michigan Medicine

At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our five hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes the top ranked U-M Medical School and University of Michigan Health, which includes the C.S. Mott Children's Hospital, Von Voigtlander Women's Hospital, University Hospital, the Frankel Cardiovascular Center, Kellogg Eye Center, University of Michigan Health West and the Rogel Cancer Center. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million.

About VeinWay
VeinWay provides physicians with a dedicated, purpose-built tool to create a pathway through a clogged vein such that physicians can easily restore blood flow through the vein to the heart. This tool is built to expand the physician's ability to safely cross a variety of complicated blockages that were previously un-crossable, as well as shorten the time to cross.

You Must Be Logged In To Post A Comment